Monthly Archives: November 2018

A New Piece in the Prostate Cancer Puzzle

In a promising new development, scientists working tirelessly at the Centre for Cancer Biology (CCB) have identified that high levels of a protein called ‘quaking’ contributes to the poor outlook for prostate cancer tumours that have become resistant to chemotherapy and other treatments. Continue reading

Cancer killing T cells fighting prostate cancer

Cancer fighting T cells already present in our blood may hold the key to fighting tumours in prostate cancer, replacing the need for invasive surgery.

Research from the Basil Hetzel Institute for Translational Health Research (BHI), has found that activated T cells delivered to a localised area enhances their cancer killing potential. This is particularly effective when treating the early stages of prostate and breast cancers, which develop in a confined space. Continue reading